Drugs Made In America Acquisition (DMII) Operating Expenses (2025)
Drugs Made In America Acquisition (DMII) reported Operating Expenses of $235472.0 for Q4 2025, up 51.42% quarter-over-quarter from $155513.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Operating Expenses (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Operating Expenses data on file, last reported at $235472.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 427,850.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 84,204.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 482,100.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.15 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 201,744.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 225,545.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 612,993.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 198,194.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 966,218.00 |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | 235,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 235,472.00 |
| Sep 30, 2025 | 155,513.00 |